These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 6091869

  • 21. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S, Bhalla K, Arlin Z, Howe CW.
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [Abstract] [Full Text] [Related]

  • 22. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.
    Abe I, Saito S, Hori K, Suzuki M, Sato H.
    Cancer Res; 1982 Jul; 42(7):2846-51. PubMed ID: 7083175
    [Abstract] [Full Text] [Related]

  • 23. Concordant changes of pyrimidine metabolism in blasts of two cases of acute myeloid leukemia after repeated treatment with ara-C in vivo.
    Chiba P, Tihan T, Szekeres T, Salamon J, Kraupp M, Eher R, Köller U, Knapp W.
    Leukemia; 1990 Nov; 4(11):761-5. PubMed ID: 2232889
    [Abstract] [Full Text] [Related]

  • 24. Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine.
    Liliemark JO, Plunkett W, Dixon DO.
    Cancer Res; 1985 Nov; 45(11 Pt 2):5952-7. PubMed ID: 4053067
    [Abstract] [Full Text] [Related]

  • 25. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
    Grant S, Turner AJ, Bartimole TM, Nelms PA, Joe VC, Jarvis WD.
    Oncol Res; 1994 Nov; 6(2):87-99. PubMed ID: 7949469
    [Abstract] [Full Text] [Related]

  • 26. Role of uridine triphosphate in the phosphorylation of 1-beta-D-arabinofuranosylcytosine by Ehrlich ascites tumor cells.
    White JC, Hines LH.
    Cancer Res; 1987 Apr 01; 47(7):1820-4. PubMed ID: 3028615
    [Abstract] [Full Text] [Related]

  • 27. Schedule-dependent enhancement of 1-beta-D-arabinofuranosylcytosine incorporation into HL-60 DNA by deoxyguanosine.
    Ross DD, Akman SA, Joneckis CC, Yang E, Bachur NR.
    Cancer Res; 1984 Apr 01; 44(4):1530-5. PubMed ID: 6584206
    [Abstract] [Full Text] [Related]

  • 28. A new sensitive method for determination of intracellular 1-beta-D-arabinofuranosylcytosine 5'-triphosphate content in human materials in vivo.
    Yamauchi T, Ueda T, Nakamura T.
    Cancer Res; 1996 Apr 15; 56(8):1800-4. PubMed ID: 8620496
    [Abstract] [Full Text] [Related]

  • 29. Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity.
    Honma Y, Onozuka Y, Okabe-Kado J, Kasukabe T, Hozumi M.
    Cancer Res; 1991 Sep 01; 51(17):4535-8. PubMed ID: 1873797
    [Abstract] [Full Text] [Related]

  • 30. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
    Bergman AM, Kuiper CM, Voorn DA, Comijn EM, Myhren F, Sandvold ML, Hendriks HR, Peters GJ.
    Biochem Pharmacol; 2004 Feb 01; 67(3):503-11. PubMed ID: 15037202
    [Abstract] [Full Text] [Related]

  • 31. Isolation and characterization of an anthracycline-resistant human leukemic cell line.
    Bhalla K, Hindenburg A, Taub RN, Grant S.
    Cancer Res; 1985 Aug 01; 45(8):3657-62. PubMed ID: 3860286
    [Abstract] [Full Text] [Related]

  • 32. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N, Ishii Y, Matsuda A, Honma Y.
    Cancer Res; 2001 Jan 01; 61(1):178-85. PubMed ID: 11196157
    [Abstract] [Full Text] [Related]

  • 33. Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells.
    Kanno S, Hiura T, Ohtake T, Koiwai K, Suzuki H, Ujibe M, Ishikawa M.
    Clin Chim Acta; 2007 Feb 01; 377(1-2):144-9. PubMed ID: 17097625
    [Abstract] [Full Text] [Related]

  • 34. Characterization of cytarabine-resistant leukemic cell lines established from five different blood cell lineages using gene expression and proteomic analyses.
    Negoro E, Yamauchi T, Urasaki Y, Nishi R, Hori H, Ueda T.
    Int J Oncol; 2011 Apr 01; 38(4):911-9. PubMed ID: 21290089
    [Abstract] [Full Text] [Related]

  • 35. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia.
    Jahns-Streubel G, Reuter C, Unterhalt M, Schleyer E, Wörmann B, Büchner T, Hiddemann W.
    Leukemia; 1995 Nov 01; 9(11):1857-63. PubMed ID: 7475275
    [Abstract] [Full Text] [Related]

  • 36. Potential for selective enhancement of the in vivo metabolism of 1-beta-D-arabinofuranosylcytosine in rats by thymidine pretreatment.
    Danhauser LL, Rustum YM.
    Cancer Res; 1985 May 01; 45(5):2002-7. PubMed ID: 3986756
    [Abstract] [Full Text] [Related]

  • 37. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
    Gandhi V, Estey E, Du M, Nowak B, Keating MJ, Plunkett W.
    Clin Cancer Res; 1995 Feb 01; 1(2):169-78. PubMed ID: 9815970
    [Abstract] [Full Text] [Related]

  • 38. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60).
    Vilpo JA, Vilpo LM.
    Cancer Res; 1988 Jun 01; 48(11):3117-22. PubMed ID: 3163271
    [Abstract] [Full Text] [Related]

  • 39. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW, Huang X, Ge Y, Dutcher JA, Stout ML, Mohammad RM, Ravindranath Y, Matherly LH.
    Cancer Res; 2000 Nov 15; 60(22):6421-6. PubMed ID: 11103808
    [Abstract] [Full Text] [Related]

  • 40. Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate.
    Liliemark JO, Plunkett W.
    Cancer Res; 1986 Mar 15; 46(3):1079-83. PubMed ID: 3484676
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.